American Healthcare REIT (AHR) FY2023 results: revenue $1.9 billion, up 32.2% on the year
American Healthcare REIT, Inc. (AHR) reported revenue of $1.9 billion for fiscal 2023, the year ended 31 December 2023, up 32.2% on the year before. Net income was -$71 million, and diluted earnings per share $-1.08. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2026.
Revenue
$1.9 billion
+32.2% on the year
FY2016FY2023
Operating margin
16.4%
21.4% a year earlier
FY2016FY2023
Net income
-$71 million
FY2016FY2023
Diluted EPS
-$1.08
FY2016FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
98.5
148
17.9
-33.3%
Capital expenditure
n/a
7.5
n/a
Free cash flow
n/a
140
n/a
Free cash flow margin
n/a
9.9%
n/a
Cash from investing
9.4
-119
-139
Cash from financing
-129
-42.9
94.1
Depreciation and amortisation
183
168
133
+8.7%
Share-based compensation
5.5
3.9
8.8
+39.9%
Buybacks
0.5
20.7
0.4
-97.7%
Dividends paid
76.3
51.1
22.8
+49.2%
Dividend per share
$1.00
$1.60
$0.68
-37.5%
Diluted shares, weighted
66m
66m
50m
+0.4%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
1,270
1,400
1,581
-9.3%
Non-controlling interest
155
168
176
-7.6%
Debt
2,526
2,512
2,322
+0.6%
Other liabilities
626
707
501
-11.5%
Total liabilities and equity
4,578
4,787
4,580
-4.4%
Goodwill
3.3
232
210
-98.6%
Intangible assets
180
236
249
-23.6%
Securities held for sale or to maturity
86.9
83.0
79.3
+4.7%
Cash and equivalents
43.4
65.1
81.6
-33.2%
Inventory
19.5
19.8
18.9
-1.5%
Other assets
4,244
4,151
3,942
+2.2%
Total assets
4,578
4,787
4,580
-4.4%
10-K for the year ended 31 December 2023, filed 27 February 2026: the filing.